New! Learn more about the all new DeepDyve personalized home page where you can quickly skim your favorite journals all from one place

European Journal of Cancer Supplements Volume 7 Issue 3

2012
- Volume 10
2011
- Volume 9
  - Issue 2 (Oct)
  - Issue 1 (Apr)
2010
- Volume 8
2009
- Volume 7
2008
- Volume 6
2007
- Volume 5
2006
- Volume 4
2005
- Volume 3
2004
- Volume 2
2003
- Volume 1

Bookmark
More Like This sm0X7jOIKd Rentable

G2 Efficacy of BSI-201, a poly (ADP-ribose) polymerase-1 (PARP1) inhibitor, in combination with gemcitabine/carboplatin (G/C) in patients with metastatic triple-negative breast cancer (TNBC): results of a randomized phase II trial

O'Shaughnessy, J.; Osborne, C.; Pippen, J.; Yoffe, M.; Patt, D.; Monaghan, G.; Rocha, C.; Ossovskaya, V.; Sherman, B.; Bradley, C.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009
Bookmark
More Like This xDQfFw0jqA Rentable

4BA A randomized phase III study comparing epirubicin, docetaxel, and capecitabine (EDC) to epirubicin and docetaxel (ED) as neoadjuvant treatment for early breast cancer – first results of the Austrian Breast and Colorectal Cancer Study Group-Trial 24 (ABCSG-24)

Steger, G.G.; Greil, R.; Jakesz, R.; Lang, A.; Mlineritsch, B.; Melbinger-Zeinitzer, E.; Marth, C.; Samonigg, H.; Kubista, E.; Gnant, M.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009
Bookmark
More Like This UT0J8FxWIz Rentable

19LBA HPV-associated p16-expression and response to radiobiological modifications of radiotherapy in head and neck cancer: results from the randomised DAHANCA trials

Lassen, P.; Eriksen, J.G.; Krogdahl, A.; Specht, L.; Overgaard, M.; Andersen, E.; Johansen, J.; Andersen, L.J.; Overgaard, J.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009
Bookmark
More Like This Ob8y2N9fHa Rentable

31LBA β-arrestin-dependent signaling by IGF-1R regulates the Ras induced transformation of mammalian cells

Zheng, H.; Natalishvili, N.; Mateoiu, C.; Girnita, A.; Girnita, L.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009
Bookmark
More Like This qp0a4xGihj Rentable

11LBA Cell reprogramming by hypoxia

Varesio, L.; Versteeg, R.; Blengio, F.; Barla, A.; Bosco, M.C.; Fardin, P.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009
Bookmark
More Like This Q1MbAcHl1L Rentable

57LBA Aprepitant (APR) for the prevention of chemotherapy-induced nausea and vomiting (CINV) associated with moderately emetogenic chemotherapy (MEC) in breast and non-breast cancers

Gralla, R.; Rapoport, B.; Brown, C.; Street, J.C.; Hardwick, J.S.; Carides, A.D.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009
Bookmark
More Like This ol44j9ujQ9 Rentable

51LBA Completion of a Phase II study of sorafenib for advanced thyroid cancer

Brose, M.S.; Troxel, A.B.; Harlacker, K.; Redlinger, M.; Chalian, A.A.; Loevner, L.A.; Mandel, S.J.; O'Dwyer, P.J.; Keefe, S.M.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009
Bookmark
More Like This Cww0x90l0j Rentable

20LBA A double-blind, randomized study of denosumab versus zoledronic acid for the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma

Henry, D.; von Moos, R.; Vadhan-Raj, S.; Hungria, V.; Spencer, A.; Hirsh, V.; Wang, J.; Jun, S.; Yeh, H.; Dansey, R.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009
Bookmark
More Like This 0L03JYrocO Rentable

10LBA Randomized phase 3 study of panitumumab with FOLFOX4 compared to FOLFOX4 alone as 1 st -line treatment (tx) for metastatic colorectal cancer (mCRC): the PRIME trial

Douillard, J.; Siena, S.; Cassidy, J.; Tabernero, J.; Burkes, R.; Barugel, M.E.; Humblet, Y.; Cunningham, D.; Wolf, M.; Gansert, J.L.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009
Bookmark
More Like This jO0Bz0Nyw3 Rentable

15LBA Intermittent versus continuous oxaliplatin-based combination chemotherapy in patients with advanced colorectal cancer: a randomised non-inferiority trial (MRC COIN)

Adams, R.; Wilson, R.; Seymour, M.T.; Meade, A.M.; Madi, A.; Cassidy, J.; Fisher, D.; Kenny, S.; Kaplan, R.; Maughan, T.S.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009

European Journal of Cancer Supplements Volume 7 Issue 3

G2 Efficacy of BSI-201, a poly (ADP-ribose) polymerase-1 (PARP1) inhibitor, in combination with gemcitabine/carboplatin (G/C) in patients with metastatic triple-negative breast cancer (TNBC): results of a randomized phase II trial

O'Shaughnessy, J.; Osborne, C.; Pippen, J.; Yoffe, M.; Patt, D.; Monaghan, G.; Rocha, C.; Ossovskaya, V.; Sherman, B.; Bradley, C.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009

4BA A randomized phase III study comparing epirubicin, docetaxel, and capecitabine (EDC) to epirubicin and docetaxel (ED) as neoadjuvant treatment for early breast cancer – first results of the Austrian Breast and Colorectal Cancer Study Group-Trial 24 (ABCSG-24)

Steger, G.G.; Greil, R.; Jakesz, R.; Lang, A.; Mlineritsch, B.; Melbinger-Zeinitzer, E.; Marth, C.; Samonigg, H.; Kubista, E.; Gnant, M.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009

19LBA HPV-associated p16-expression and response to radiobiological modifications of radiotherapy in head and neck cancer: results from the randomised DAHANCA trials

Lassen, P.; Eriksen, J.G.; Krogdahl, A.; Specht, L.; Overgaard, M.; Andersen, E.; Johansen, J.; Andersen, L.J.; Overgaard, J.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009

31LBA β-arrestin-dependent signaling by IGF-1R regulates the Ras induced transformation of mammalian cells

Zheng, H.; Natalishvili, N.; Mateoiu, C.; Girnita, A.; Girnita, L.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009

11LBA Cell reprogramming by hypoxia

Varesio, L.; Versteeg, R.; Blengio, F.; Barla, A.; Bosco, M.C.; Fardin, P.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009

57LBA Aprepitant (APR) for the prevention of chemotherapy-induced nausea and vomiting (CINV) associated with moderately emetogenic chemotherapy (MEC) in breast and non-breast cancers

Gralla, R.; Rapoport, B.; Brown, C.; Street, J.C.; Hardwick, J.S.; Carides, A.D.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009

51LBA Completion of a Phase II study of sorafenib for advanced thyroid cancer

Brose, M.S.; Troxel, A.B.; Harlacker, K.; Redlinger, M.; Chalian, A.A.; Loevner, L.A.; Mandel, S.J.; O'Dwyer, P.J.; Keefe, S.M.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009

20LBA A double-blind, randomized study of denosumab versus zoledronic acid for the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma

Henry, D.; von Moos, R.; Vadhan-Raj, S.; Hungria, V.; Spencer, A.; Hirsh, V.; Wang, J.; Jun, S.; Yeh, H.; Dansey, R.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009

10LBA Randomized phase 3 study of panitumumab with FOLFOX4 compared to FOLFOX4 alone as 1 st -line treatment (tx) for metastatic colorectal cancer (mCRC): the PRIME trial

Douillard, J.; Siena, S.; Cassidy, J.; Tabernero, J.; Burkes, R.; Barugel, M.E.; Humblet, Y.; Cunningham, D.; Wolf, M.; Gansert, J.L.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009

15LBA Intermittent versus continuous oxaliplatin-based combination chemotherapy in patients with advanced colorectal cancer: a randomised non-inferiority trial (MRC COIN)

Adams, R.; Wilson, R.; Seymour, M.T.; Meade, A.M.; Madi, A.; Cassidy, J.; Fisher, D.; Kenny, S.; Kaplan, R.; Maughan, T.S.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009

Advanced Filters:

Specific Data Sources:

European Journal of Cancer Supplements Volume 7 Issue 3

1 - 10 of 71 articles

O'Shaughnessy, J.; Osborne, C.; Pippen, J.; Yoffe, M.; Patt, D.; Monaghan, G.; Rocha, C.; Ossovskaya, V.; Sherman, B.; Bradley, C.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009

Steger, G.G.; Greil, R.; Jakesz, R.; Lang, A.; Mlineritsch, B.; Melbinger-Zeinitzer, E.; Marth, C.; Samonigg, H.; Kubista, E.; Gnant, M.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009

Lassen, P.; Eriksen, J.G.; Krogdahl, A.; Specht, L.; Overgaard, M.; Andersen, E.; Johansen, J.; Andersen, L.J.; Overgaard, J.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009

Zheng, H.; Natalishvili, N.; Mateoiu, C.; Girnita, A.; Girnita, L.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009

Varesio, L.; Versteeg, R.; Blengio, F.; Barla, A.; Bosco, M.C.; Fardin, P.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009

Gralla, R.; Rapoport, B.; Brown, C.; Street, J.C.; Hardwick, J.S.; Carides, A.D.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009

Brose, M.S.; Troxel, A.B.; Harlacker, K.; Redlinger, M.; Chalian, A.A.; Loevner, L.A.; Mandel, S.J.; O'Dwyer, P.J.; Keefe, S.M.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009

Henry, D.; von Moos, R.; Vadhan-Raj, S.; Hungria, V.; Spencer, A.; Hirsh, V.; Wang, J.; Jun, S.; Yeh, H.; Dansey, R.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009

Douillard, J.; Siena, S.; Cassidy, J.; Tabernero, J.; Burkes, R.; Barugel, M.E.; Humblet, Y.; Cunningham, D.; Wolf, M.; Gansert, J.L.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009

Adams, R.; Wilson, R.; Seymour, M.T.; Meade, A.M.; Madi, A.; Cassidy, J.; Fisher, D.; Kenny, S.; Kaplan, R.; Maughan, T.S.

Follow European Journal of Cancer Supplements , Volume 7 (3) Elsevier – Sep 1, 2009